drugset / Trial / NCT04587206

A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348

NCT04587206

Phase 1 Completed 62 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-348

Timeline

Start
2020-10-15
Primary completion
2020-12-30
Completion
2021-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-348 Unknown Oral
Subject CKD-828 Unknown Oral
Subject D097 Unknown Oral
Subject D337 Unknown Oral

Indications

No indication recorded.